UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Parkside Financial Bank & Trust

Parkside Financial Bank & Trust cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 6.2% during the second quarter, HoldingsChannel.com reports. The fund owned 3,369 shares of the healthcare conglomerate’s stock after selling 221 shares during the period. Parkside Financial Bank & Trust’s holdings in UnitedHealth Group were worth $1,731,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. NorthCrest Asset Manangement LLC raised its stake in UnitedHealth Group by 9.5% during the first quarter. NorthCrest Asset Manangement LLC now owns 518 shares of the healthcare conglomerate’s stock worth $264,000 after purchasing an additional 45 shares during the period. Cullinan Associates Inc. raised its stake in UnitedHealth Group by 2.1% during the second quarter. Cullinan Associates Inc. now owns 27,068 shares of the healthcare conglomerate’s stock worth $13,903,000 after purchasing an additional 555 shares during the period. 626 Financial LLC raised its stake in UnitedHealth Group by 1.5% during the second quarter. 626 Financial LLC now owns 2,387 shares of the healthcare conglomerate’s stock worth $1,224,000 after purchasing an additional 35 shares during the period. EverSource Wealth Advisors LLC raised its stake in UnitedHealth Group by 67.7% during the first quarter. EverSource Wealth Advisors LLC now owns 2,557 shares of the healthcare conglomerate’s stock worth $1,303,000 after purchasing an additional 1,032 shares during the period. Finally, TPG Financial Advisors LLC raised its stake in shares of UnitedHealth Group by 8.6% in the 2nd quarter. TPG Financial Advisors LLC now owns 2,423 shares of the healthcare conglomerate’s stock valued at $1,245,000 after acquiring an additional 192 shares during the period. 87.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. Loop Capital assumed coverage on shares of UnitedHealth Group in a research note on Thursday, June 16th. They issued a “buy” rating and a $575.00 price target on the stock. Mizuho boosted their price target on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, August 10th. Raymond James lifted their price objective on shares of UnitedHealth Group from $620.00 to $635.00 in a report on Thursday. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a report on Thursday, September 8th. Three equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $586.40.

UnitedHealth Group Trading Up 1.1 %

Shares of UnitedHealth Group stock opened at $517.46 on Friday. The company has a fifty day simple moving average of $530.11 and a 200-day simple moving average of $512.45. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60. The stock has a market cap of $484.02 billion, a price-to-earnings ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. During the same quarter in the prior year, the business posted $4.70 EPS. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were given a $1.65 dividend. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 annualized dividend and a yield of 1.28%. UnitedHealth Group’s dividend payout ratio (DPR) is 34.46%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Andrew Witty sold 11,376 shares of the company’s stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. Insiders sold a total of 139,051 shares of company stock worth $74,450,958 in the last 90 days. 0.40% of the stock is owned by insiders.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.